Clinical trial
Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary…
NCT00442234 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00442234 |
|---|---|
| Title | Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism |
| Official title | Pharmacokinetic/Pharmacodynamic Study of Monteplase ("Cleactor") in Acute Pulmonary Embolism |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | Eisai Co., Ltd. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Monteplase |
| Enrollment | 5 |
| Start date | May 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Mar 1, 2007 |
| Last update posted | Oct 18, 2018 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: